UFP Technologies, Inc. acquired CI Medical Inc.

UFP Technologies, Inc. (UFPT) completed the acquisition of CI Medical Inc. on September 7, 2026. The company's stock has seen a 5-day change of 288.79 USD, a 1st Jan change of +0.79%, and a year-to-date change of +30.07%.

Original reporting
Published Sep 7, 2026, 6:05 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 8, 2026, 12:10 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$UFPT
Bullish
high confidence
Mentioned
$UFPT
Relevance
7/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$UFPTBullishHigh
01

Why it matters

The acquisition expands UFP's product offerings in the medical device space, potentially boosting revenue and market share.

02

Market read

Primary M&A news for UFPT; likely to move the stock on the day of announcement.

03

What to watch

No disclosed purchase price; financing method and balance‑sheet impact remain unclear.

Relevance 7/10Novelty 8/10Timing: pre-market

Background

UFP Technologies (NasdaqCM:UFPT) announced the completion of its acquisition of CI Medical Inc. on September 7, 2026.

Company-level read

Ticker impact

$UFPTBullishHigh confidence
Context

UFP Technologies completed the acquisition of CI Medical Inc., announced on Sep 7, 2026.

Expected impact

Short-term upside as investors price in synergies; medium-term depends on integration execution.

Evidence & confidence

M&A announcements are typically priced in quickly; no valuation disclosed but the transaction is material for a mid‑cap.

Market effects

Adds a medical device line to UFP's manufacturing portfolio, may pressure peers in the med‑tech sector.

U.S. market focus; limited regional spillover.

Modest; primarily affects UFP and its niche market.

Counterpoint

Integration risks could outweigh synergies, leading to a pullback after the initial rally.

Key entities

  • UFP Technologies, Inc.

    Acquirer, listed on NasdaqCM under UFPT.

  • CI Medical Inc.

    Target of the acquisition, not publicly listed.

Related articles

$UFPTMed

UFP Technologies (UFPT) Shares Just Moved, So What Is Driving Attention Now?

UFP Technologies (UFPT) reported Q3 sales of $172.43M and net income of $20.62M, up from the previous year. Shares rose 17.66% to $329.82 on the news, extending a 15.32% 7-day return. Analysts see a fair value of $355, citing growth in medical device components and packaging. However, UFPT trades at 33.4x earnings, higher than the industry average of 23.9x, raising valuation concerns.

$UFPTMed

UFP Technologies (UFPT) Q3 2026 Earnings Call Transcript

UFP Technologies (UFPT) reported Q3 2026 sales up 11.6%, with organic growth at 11.1%. Gross margin improved to 29.4% from 27.7% last year. Adjusted EPS was $2.88, up significantly. The company is investing in growth, including acquisitions like CI Medical, and expanding credit facilities. AJR operations are behind schedule but expected to improve in 2027. Management remains optimistic about long-term growth and shareholder value.

$UFPTHighAI 8/10

UFP Technologies (NASDAQ:UFPT) delivers impressive Q3 2026

UFP Technologies (UFPT) reported Q3 2026 revenue of $172.4M, up 11.6% YoY and 3.2% above estimates. Adjusted EPS of $2.88 beat estimates by 7.3%. Operating margin held steady at 16%. The company cited operational improvements and growth in new programs. Analysts expect 5.6% revenue growth over the next 12 months.

$UFPTHigh

UFP Technologies Announces Strong Q3 Results

UFP TECHNOLOGIES INC (UFPT) filed an SEC Form 8-K — Results of Operations and Financial Condition. UFP Technologies Announces Strong Q3 Results Newburyport, Mass., November 3, 2026. UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly